AbbVie Inc (ABBV)
175.58
+4.06
(+2.37%)
USD |
NYSE |
Dec 20, 16:00
175.50
-0.08
(-0.05%)
After-Hours: 20:00
AbbVie Cash from Investing (Quarterly): -8.256B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Johnson & Johnson | -3.128B |
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Pfizer Inc | -2.057B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.447B |
| Cash from Financing (Quarterly) | -3.072B |
| Free Cash Flow | 15.62B |
| Free Cash Flow Per Share (Quarterly) | 2.933 |
| Free Cash Flow to Equity (Quarterly) | 4.753B |
| Free Cash Flow to Firm (Quarterly) | 5.642B |
| Free Cash Flow Yield | 5.02% |